Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples

Journal of Clinical Microbiology

Volumn 36, Issue 7, 1998, Pages 1953-1958

  Denton, Miles ^a,b,c   Todd, Neil J ^a   Kerr, Kevin G ^b   Hawkey, Peter M ^b   Littlewood, James M ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c Old Medical School   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; CHILD; CYSTIC FIBROSIS; ENVIRONMENTAL FACTOR; FEMALE; HOSPITAL INFECTION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STENOTROPHOMONAS MALTOPHILIA;

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; NEGIBACTERIA; STENOTROPHOMONAS MALTOPHILIA;

EID: 0031862377     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.7.1953-1958.1998     Document Type: Article

References (38)

1. Ballestero, S., I. Virseda, H. Escobar, L. Suarez, and F. Baquero. 1995. Stenoirophomonas maltophilia in cystic fibrosis patients. Eur. J. Clin. Microbiol. Infect. Dis. 14:728-729.
2. Bingen, E. H., E. Denamur, N. Y. Lambert-Zechovsky, A. Bourdois, P. Mariani-Kurkdjian, J.-P. Cezard, J. Navarro, and J. Elion. 1991. DNA restriction fragment length polymorphism differentiates crossed from independent infections in nosocomial Xanthomonas maltophilia bacteremia. J. Clin. Microbiol. 29:1348-1350.
3. British Society for Antimicrobial Chemotherapy. 1991. A guide to sensitivity testing. J. Antimicrob. Chemother. 27(Suppl. D):1-50.
4. Butler, S. L., C. J. Doherty, J. E. Hughes, J. W. Nelson, and J. R. W. Govan. 1995. Burkholderia cepacia and cystic fibrosis: do natural environments present a potential hazard? J. Clin. Microbiol. 33:1001-1004.
5. Chatelut, M., J. L. Dournes, G. Chabanon, and N. Marty. 1995. Epidemiological typing of Stenotrophomonas (Xanthomonas) maltophilia by PCR. J. Clin. Microbiol. 33:912-914.
6. Davin-Regli, A., C. Bollet, J. P. Auffray, P. Saux, and P. De Micco. 1996. Use of random amplified polymorphic DNA for epidemiological typing of Stenotrophomonas maltophilia. J. Hosp. Infect. 32:39-50.
7. De Lamballerie, X., C. Zandotti, C. Vignoli, C. Bollet, and P. de Micco. 1992. A one step microbial DNA extraction method using "Chelex 100" suitable for gene amplification. Res. Microbiol. 143:785-790.
8. Denton, M. 1997. Stenotrophomonas maltophilia: an emerging problem in cystic fibrosis patients. Rev. Med. Microbiol. 8:15-19.
9. Denton, M., N. J. Todd, and J. M. Littlewood. 1996. Role of antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients. Eur. J. Clin. Microbiol. Infect. Dis. 15:402-405.
10. Doring, G., M. Ulrich, W. Muller, J. Bitzer, L. Schmidt-Koenig, L. Munst, H. Grupp, C. Wolz, M. Stern, and K. Botzenhardt. 1991. Generation of Pseudomonas aeruginosa aerosols during handwashing from contaminated sink drains, transmission to hands of hospital personnel, and its prevention by use of a new heating device. Zentralbl. Hyg. 191:494-505.
11. Elting, L. S., N. Khardori, G. P. Bodey, and V. Fanstein. 1990. Nosocomial infection caused by Xanthomonas maltophilia: a case-control study of pre-disposing factors. Infect. Control Hosp. Epidemiol. 11:134-138.
12. Feeley, T. W., G. C. du Moulin, J. Hedley-White, L. S. Bushnell, J. P. Gilbert, and D. S. Feingold. 1975. Aerosol polymyxin and pneumonia in seriously ill patients. N. Engl. J. Med. 293:471-475.
13. Fenton, J. J., H. H. Harsch, and D. Klein. 1973. Production of volatile nitrogenous compounds from the degradation of streptomycin by Pseudomonas maltophilia. J. Bacteriol. 116:1267-1272.
14. Fisher, M. C., S. S. Long, E. M. Roberts, J. M. Dunn, and R. K. Balsara. 1981. Pseudomonas maltophilia bacteremia in children undergoing open heart surgery. J. Am. Med. Assoc. 246:1571-1574.
15. Flaherty, J. P., S. Garcia-Houchins, R. Chudy, and P. M. Arnow. 1993. An outbreak of Gram-negative bacteremia traced to contaminated O-rings in reprocessed dialyzers. Ann. Intern. Med. 119:1072-1078.
16. Garrison, M. W., D. E. Anderson, D. M. Campbell, K. C. Carroll, C. L. Malone, J. D. Anderson, R. J. Hollis, and M. A. Pfaller. 1996. Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and an in vitro pharmacodynamic chamber model. Antimicrob. Agents Chemother. 40:2859-2864.
17. Gerner-Smidt, P., B. Bruun, M. Arpi, and J. Schmidt. 1995. Diversity of nosocomial Xanthomonas maltophilia (Stenotrophomonas maltophilia) as determined by ribotyping. Eur. J. Clin. Microbiol. Infect. Dis. 14:137-140.
18. Hutchinson, G. R., S. Parker, J. A. Pryor, F. Duncan-Skingle, P. N. Hoffman, M. E. Hodson, M. E. Kaufmann, and T. L. Pitt. 1996. Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis. J. Clin. Microbiol. 34:584-587.
19. Kerr, K. G., J. Anson, and P. M. Hawkey. 1994. Adherence of clinical and environmental strains of Xanthomonas maltophilia to plastic material, abstr. B-339, p. 89. In Abstracts of the 94th General Meeting of the American Society for Microbiology, Las Vegas, Nev. American Society for Microbiology, Washington, D.C.
20. Kerr, K. G., M. Denton, N. J. Todd, C. M. Corps, P. Kumari, and P. M. Hawkey. 1996. A novel selective culture medium for the isolation of Stenotrophomonas maltophilia. Eur. J. Clin. Microbiol. Infect. Dis. 15:607-610.
21. Khardori, N., L. Elting, E. Wong, B. Schable, and G. P. Bodey. 1990. Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev. Infect. Dis. 12:997-1003.
22. Laing, F. P. Y., K. Ramotar, R. R. Read, N. Alfieri, A. Kureishi, E. A. Henderson, and T. J. Louie. 1995. Molecular epidemiology of Xanthomonas maltophilia colonization and infection in the hospital environment. J. Clin. Microbiol. 33:513-518.
23. Manian, F. A., L. Meyer, J. Jenne, A. Owen, and T. Taff. 1996. Loss of antimicrobial susceptibility in aerobic gram negative bacilli repeatedly isolated from intensive care patients. Infect. Control Hosp. Epidemiol. 17:222-226.
24. Medical Services Directorate. 1993. Ice cubes: infection caused by Xanthomonas maltophilia. Department of Health, London, United Kingdom. (Hazard 93:42.)
25. Morrison, A. J., Jr., K. K. Hoffman, and R. P. Wenzel. 1986. Associated mortality and clinical characteristics of nosocomial Pseudomonas maltophilia in a university hospital. J. Clin. Microbiol. 24:52-55.
26. Mortensen, J. E., M. C. Fisher, and J. J. LiPuma. 1995. Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment. Infect. Control Hosp. Epidemiol. 56:152-162.
27. Orr, K., F. K. Gould, P. R. Sisson, N. F. Lighfoot, R. Freeman, and D. Burdess. 1991. Rapid inter-strain comparison by pyrolysis mass spectrometry in nosocomial infection with Xanthomonas maltophilia. J. Hosp. Infect. 17: 187-195.
28. Sader, H. S., A. C. Pignatari, R. Frei, R. J. Hollis, and R. N. Jones. 1994. Pulsed-field gel electrophoresis of restriction-digested genomic DNA and antimicrobial susceptibility of Xanthomonas maltophilia strains from Brazil, Switzerland, and the USA. J. Antimicrob. Chemother. 33:615-618.
29. Spencer, R. C. 1995. The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia. J. Hosp. Infect. 30(Suppl.):453-464.
30. Talon, D., P. Bailly, R. Leprat, C. Godard, E. Deconnink, J.-Y. Cahn, and Y. Michel-Briand. 1994. Typing of hospital strains of Xanthomonas maltophilia by pulsed-field gel electrophoresis. J. Hosp. Infect. 27:209-217.
31. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
32. Van Couwenberghe, C. J., S. H. Cohen, Y. J. Tang, P. H. Gumerlock, and J. Silva, Jr. 1995. Genomic fingerprinting of epidemic and endemic strains of Stenotrophomonas maltophilia (formerly Xanthomonas maltophilia) by arbitrarily primed PCR. J. Clin. Microbiol. 33:1289-1291.
33. Vanholder, R., E. Vanhaecke, and S. Ringoir. 1992. Pseudomonas septicemia due to deficient disinfectant mixing during reuse. Int. J. Artific. Org. 15:19-24.
34. Victor, M. A., M. Arpi, B. Bruun, V. Jonsson, and M. M. Hansen. 1994. Xanthomonas maltophilia bacteremia in immunocompromised hematological patients. Scand. J. Infect. Dis. 26:163-170.
35. Villarino, M. E., L. E. Stevens, B. Schable, G. Mayers, J. M. Miller, J. P. Burke, and W. R. Jarvis. 1992. Risk factors for epidemic Xanthomonas maltophilia infection/colonisation in intensive care unit patients. Infect. Control Hosp. Epidemiol. 13:201-206.
36. Vu-Thien, H., D. Moissenet, M. Valcin, C. Dulot, G. Tournier, and A. Garbarg-Chenon. 1996. Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center. Eur. J. Clin. Microbiol. Infect. Dis. 15:876-879.
37. Wishart, M. M., and T. V. Riley. 1976. Infection with Pseudomonas maltophilia: hospital outbreak due to contaminated disinfectant. Med. J. Aust. 2:710-712.
38. Yao, J. D. C., J. M. Conly, and M. Krajden. 1995. Molecular typing of Stenotrophomonas (Xanthomonas) maltophilia by DNA macrorestriction analysis and random amplified polymorphic DNA analysis. J. Clin. Microbiol. 33:2195-2198.